Saladax Biomedical Inc. / CESAR Austria / CESAR Germany / Saladax Biomedical Collaborate / Myriad Genetic Laboratories Inc. / Myriad Genetics Inc. / Saladax Media Contact Tiberend Strategic Advisors Inc. / /
Continent
Europe / /
Country
Switzerland / Japan / Austria / United States / Canada / / /
Event
FDA Phase / /
IndustryTerm
pharmaceutical industry / cancer treatment / pharmaceutical / dose management technology / dose management / diagnostic products / appropriate infrastructure / assay technology / be measured using Saladax’s assay technology / /
MedicalCondition
colorectal cancer / diarrhea / head cancers / disease / metastatic colorectal cancer / mucositis / neck cancers / /
MedicalTreatment
radiation therapy / chemotherapy / surgery / /
Organization
CESAR Central Office / CESAR Central European Society for Anticancer Drug ResearchEWIV In / CESAR Central European Society for Anticancer Drug Research / Central European Society for Anticancer Drug Research / /
Person
Martin Wilhelm / Jason Rando / Adrienne Choma / Berta Moritz / / /
Position
chair / Director / Clinical Affairs / Vice President & Chief Marketing Officer / /
Product
My5-FU / fluorouracil / OnDose / Anticancer Drug / /
Technology
radiation / diagnostic tests / assay technology / chemotherapy / dose management technology / Drug Development / /
CESAR and Saladax Biomedical Collaborate on a Study of Optimized 5-FU Dosing in Colorectal Cancer Patients A single arm study in metastatic colorectal cancer patients treated with pharmacokinetic (PK) guided 5-fluorourac